Jean-Luc Samuel Francois Girardet
Chief Tech/Sci/R&D Officer at MIRUM PHARMACEUTICALS, INC.
Network origin in Jean-Luc Samuel Francois Girardet first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 24 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Université de Montpellier
12
| College/University | Other Consumer Services | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Luc Samuel Francois Girardet via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AIDS Healthcare Foundation
 AIDS Healthcare Foundation Investment Trusts/Mutual FundsMiscellaneous AIDS Healthcare Foundation is a non-profit organization which engages in the provision of medicine and advocacy programs for HIV/AIDS. The firm offers HIV and STD testing, thrift store, dental clinic, and healthcare center services. The company was founded by Michael Weinstein in 1987 and is headquartered in Los Angeles, CA. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BLUGLASS LIMITED | Semiconductors | Chief Tech/Sci/R&D Officer | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Operating Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Masters Business Admin | |
| Rice University | College/University | Masters Business Admin Doctorate Degree | |
| DIAGNOSTIC MEDICAL SYSTEMS | Medical Specialties | Corporate Officer/Principal | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Puget Sound | College/University | Undergraduate Degree Undergraduate Degree | |
| Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ASLAN PHARMACEUTICALS LIMITED | Biotechnology | Public Communications Contact | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member | |
Flashlight Therapeutics, Inc.
 Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Flashlight Therapeutics, Inc. develops therapeutics for unmet medical needs. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
WeDriveU Holdings, Inc.
 WeDriveU Holdings, Inc. Other Consumer ServicesConsumer Services WeDriveU Holdings, Inc. engages in the provision of transportation services. It offers an employee shuttle service. The company is headquartered in Burlingame, CA. | Other Consumer Services | Human Resources Officer | |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member President Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member Human Resources Officer | |
| Brii Biosciences, Inc. | Chief Executive Officer Chief Executive Officer | ||
| Brii Biosciences (Beijing) Co. Ltd. | Director/Board Member Chairman | ||
| Brii Biosciences (Hong Kong) Co. Ltd. | Director/Board Member Director/Board Member | ||
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023. | Biotechnology | Founder |
Statistics
International
| United States | 39 |
| China | 5 |
| Ireland | 3 |
| France | 3 |
| Australia | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Finance | 4 |
| Electronic Technology | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 309 |
| Corporate Officer/Principal | 133 |
| Independent Dir/Board Member | 129 |
| Chief Executive Officer | 48 |
| President | 38 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Yiu Wa Tsui | 46 |
| Patrick Heron | 42 |
| Timothy Walbert | 40 |
| Michael Grey | 32 |
| Laura Brege | 27 |
| Laurent Fischer | 23 |
| Wing Tsz Ho | 23 |
| Gregg Alton | 22 |
| Eric Bjerkholt | 21 |
| Hui Tang | 19 |
| Sona Saira Ramasastry | 19 |
| Martin Murphy | 17 |
| Zhi Hong | 16 |
| William Fairey | 15 |
- Stock Market
- Insiders
- Jean-Luc Samuel Francois Girardet
- Company connections
